Back to Browse Journals » Substance Abuse and Rehabilitation » Volume 3 » Supplement 1

Meeting the substance abuse treatment needs of lesbian, bisexual and transgender women: implications from research to practice

Authors Stevens S

Published Date February 2012 Volume 2012:3(Supplement 1) Pages 27—36

DOI http://dx.doi.org/10.2147/SAR.S26430

Received 22 September 2011, Accepted 5 November 2011, Published 1 February 2012

Sally Stevens

Southwest Institute for Research on Women (SIROW) and Department of Gender and Women’s Studies (GWS), University of Arizona, Tucson, AZ, USA

Abstract: Research on the incidence, etiology and substance abuse treatment needs of lesbian, bisexual and transgender (LBT) women is limited. Most research indicates higher levels of alcohol and drug abuse among these populations compared to their heterosexual counterparts, with recent research indicating that substance abuse is a particular concern for transgender individuals and an increasing problem among younger LBT individuals. Risk factors and reasons for substance abuse among sexual minority women are similar to those of heterosexual women, yet are substantially complicated by issues of family rejection and lack of social support, stigma and minority stress, as well as abuse and harassment. Historically, substance abuse prevention, early intervention, and clinical treatment programs were designed to meet the needs of the sexual majority population with relatively few programs designed to incorporate the specific needs of sexual minorities. This article reviews findings from previous studies and utilizes new data collected from community-based and residential substance abuse treatment programs to (1) examine issues relevant to LBT women and substance use, and (2) make recommendations for tailoring substance abuse treatment programs to meet the needs of these populations.

Keywords: lesbian, bisexual, transgender, substance abuse, family rejection, social support, stigma, minority stress, abuse, harassment

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Sequential treatment of tyrosine kinase inhibitors and chemotherapy for EGFR-mutated non-small cell lung cancer: a meta-analysis of Phase III trials

Zhang Y, Sun Y, Wang L, Ye T, Pan Y, Hu H, Yu Y, Zhao N, Song Y, Garfield D, Chen H

OncoTargets and Therapy 2013, 6:1771-1777

Published Date: 29 November 2013

Pediatric Clinical Trials: Current Scenario in the Asia Pacific Region

Saldanha LM, Nayak S, Sng A, Long ML, Schrader E, Rahman A, Lansang EZ, Wai K, Lee K

Pediatric Health, Medicine and Therapeutics 2013, 4:47-54

Published Date: 5 July 2013

Absorbable stent: focus on clinical applications and benefits

Gonzalo N, Macaya C

Vascular Health and Risk Management 2012, 8:125-132

Published Date: 29 February 2012

Evaluation of factors influencing stable microbubble test results in preterm neonates at 30–33 gestational weeks

Teslova OA, Hiroma T, Baranovskaya EI, Nakamura T

Research and Reports in Neonatology 2012, 2:5-10

Published Date: 22 February 2012

Volunteering in dementia care – a Norwegian phenomenological study

Söderhamn U, Landmark B, Aasgaard L, Eide H, Söderhamn O

Journal of Multidisciplinary Healthcare 2012, 5:61-67

Published Date: 22 February 2012

Variable sleep schedules and outcomes in children with psychopathological problems: preliminary observations

Spruyt K, Raubuck DL, Grogan K, Gozal D, Stein MA

Nature and Science of Sleep 2012, 4:9-17

Published Date: 21 February 2012

Quality of life issues and measurement in patients with psoriasis

Tan X, Feldman SR, Balkrishnan R

Psoriasis: Targets and Therapy 2012, 2:13-23

Published Date: 21 February 2012

Improving patient–physician dialog: commentary on the results of the MS Choices survey

Lugaresi A, Ziemssen T, Oreja-Guevara C, Thomas D, Verdun E

Patient Preference and Adherence 2012, 6:143-152

Published Date: 17 February 2012

Lung function decline in COPD

Tantucci C, Modina D

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:95-99

Published Date: 9 February 2012